Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Historically, clinical trials and medical research operated separately from the routine care provided in local healthcare facilities and by individual doctors. Many physicians remained unaware of ongoing research initiatives, leaving patients largely uninformed about studies that could enhance their treatment outcomes or health. Elligo has transformed this landscape by facilitating unprecedented participation in clinical research through access to a vast network of over 150 million patients and their comprehensive data, enabling doctors to present research opportunities to patients who might not otherwise encounter them. Traditional methods of recruiting participants often face challenges, such as the need for patients to travel to specific research sites, which can limit involvement. Moreover, studies indicate that patients are more inclined to participate in research when it is associated with their trusted healthcare provider, underscoring the importance of integrating clinical research into familiar medical environments. This approach not only bridges the gap between research and patient care but also empowers individuals to take part in potentially life-changing medical advancements.
Description
HEKMA is a pioneering company utilizing artificial intelligence to enhance the efficiency of clinical trials by optimizing patient recruitment, assessing trial feasibility, and fostering patient engagement.
Their comprehensive platform caters to a diverse audience, including contract research organizations (CROs), pharmaceutical sponsors, healthcare facilities, and patients, by integrating electronic health records (EHRs) with AI-driven trial matching, clinical trial management solutions, and tools for engaging patients.
The core mission of HEKMA is to minimize delays in enrollment, broaden access to clinical trials—especially for underrepresented communities—and streamline the clinical research process to ensure it is more efficient, transparent, and centered around patient needs.
With a blend of healthcare knowledge, artificial intelligence capabilities, and clinical operations expertise, HEKMA adheres to crucial industry regulations such as HIPAA, 21 CFR Part 11, GDPR, and HL7/FHIR, ensuring the highest standards of compliance.
By harnessing innovative technology, HEKMA aims to transform the landscape of clinical trials, ultimately contributing to advancements in medical research and patient care.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Elligo Health Research
Country
United States
Website
www.elligohealthresearch.com
Vendor Details
Company Name
HEKMA
Founded
2018
Country
United States
Website
www.hekma.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning
Alternatives
Alternatives
No Alternatives